Researchers find potential key to unlocking the immune system in pancreatic cancer

August 6, 2018 by Laura Oleniacz, University of North Carolina at Chapel Hill School of Medicine
Researchers find potential key to unlocking the immune system in pancreatic cancer
When IL35 is missing from preclinical models, cancer-killing immune cells (stained brown) can enter tumors.

A University of North Carolina Lineberger Comprehensive Cancer Center study may provide insights into how to overcome barriers to using immune-based treatments for pancreatic cancer, the third most deadly cancer in the United States.

In the journal Cancer Immunology Research, scientists revealed that a molecule called interleukin-35 plays a role in suppressing cancer-fighting immune in . They also reported that their preclinical study showed that knocking out IL35 worked well alongside drugs that unleash the immune system against cancer, helping to shrink tumors.

"Immunotherapies have been very effective at reducing the tumor burden in cancers such as melanoma, but this type of treatment hasn't worked right off the bat in cancer," said UNC Lineberger's Yuliya Pylayeva-Gupta, Ph.D., assistant professor in the UNC School of Medicine Department of Genetics. "That's because in pancreatic cancer, the immune cells that are present in the tumor are not the ones that respond to immunotherapy. We now better understand how these cells are suppressing the anti-tumor response."

Pancreatic cancer is one of the deadliest cancers in the United States, with just 8.5 percent of patients living five years following diagnosis. Pancreatic cancer is often diagnosed at late stages, which contributes to poor outcomes, and many cancers are not eligible for surgery because they spread to surrounding organs, or encapsulate vital blood vessels.

"We need some sort of agent that can shrink the tumors maybe to the point where we can take them out during surgery, or shrink them and obliterate them all together," she said.

Immune-based treatments known as checkpoint inhibitors have been effective in treating some cancers, including advanced melanoma. While scientists have discovered there are often within pancreatic cancer tumors, responses to immune-based treatments have been ineffective in , researchers report.

"The cells present are the ones that are what we call 'immunosuppressive cells,'" Pylayeva-Gupta said. "This cell type creates a barrier that does not allow T lymphocytes to come in."

Researchers evaluated what immunosuppressive cells are doing to create the barrier. They found cytokine IL35 suppresses the immune response that could fight the cancers. Laboratory models lacking IL35 had reduced growth, and they showed improved response by -killing cells. The researchers discovered a synergism when they added in checkpoint inhibitors to their models lacking IL35.

"We found that if we eliminated cytokine IL35 from the system, it would work to reduce ," she said. "Take away IL35, and you also see the increases in T cell lymphocytes. That's what you really want for immunotherapy."

Explore further: Study reveals secrets of "hot" and "cold" pancreatic cancer tumors

More information: Bhalchandra Mirlekar et al. IL-35 hinders endogenous anti-tumor T cell immunity and responsiveness to immunotherapy in pancreatic cancer, Cancer Immunology Research (2018). DOI: 10.1158/2326-6066.CIR-17-0710

Related Stories

Study reveals secrets of "hot" and "cold" pancreatic cancer tumors

June 28, 2018
So-called "hot" tumors filled with T cells are often considered to be more sensitive to immunotherapy compared to "cold" tumors with fewer T cells, but a clear demonstration of why has eluded cancer biologists—until now. ...

Gut bacteria determine speed of tumor growth in pancreatic cancer

March 22, 2018
The population of bacteria in the pancreas increases more than a thousand fold in patients with pancreatic cancer, and becomes dominated by species that prevent the immune system from attacking tumor cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

Immune system infighting explains pancreatic cancer's aggression

August 25, 2016
Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer. Curbing this infighting has the potential to make treatment more effective, according to a study led ...

Bladder cancer model could pave the way for better drug efficacy studies

May 21, 2018
Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients ...

Study sheds light on why some breast cancers have limited response to immunotherapy

August 21, 2017
UNC Lineberger Comprehensive Cancer Center researchers have identified a possible reason why some aggressive breast cancers are unresponsive to certain immunotherapy treatments, as well as a potential solution.

Recommended for you

Scientists discover new method of diagnosing cancer with malaria protein

August 17, 2018
In a spectacular new study, researchers from the University of Copenhagen have discovered a method of diagnosing a broad range of cancers at their early stages by utilising a particular malaria protein that sticks to cancer ...

Developing an on-off switch for breast cancer treatment

August 17, 2018
T-cells play an important role in the body's immune system, and one of their tasks is to find and destroy infection. However, T-cells struggle to identify solid, cancerous tumors in the body. A current cancer therapy is using ...

Pregnant? Eating broccoli sprouts may reduce child's chances of breast cancer later in life

August 16, 2018
Researchers at the University of Alabama at Birmingham have found that a plant-based diet is more effective in preventing breast cancer later in life for the child if the mother consumed broccoli while pregnant. The 2018 ...

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

PARP inhibitor improves progression-free survival in patients with advanced breast cancers

August 15, 2018
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over ...

New clues into how 'trash bag of the cell' traps and seals off waste

August 15, 2018
The mechanics behind how an important process within the cell traps material before recycling it has puzzled scientists for years. But Penn State researchers have gained new insight into how this process seals off waste, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.